Pharma distribution directory 2026

    Pharmaceutical Distributors in Turkey

    Turkey moves more medicine packs than any other market between Western Europe and India, and nearly all of it passes through a small set of national ecza depoları, the licensed wholesalers that deliver several times a day to 28,000 pharmacist-owned pharmacies and hold the payer-mandated stock that the reimbursement system depends on.

    The Turkish Medicines and Medical Devices Agency (TİTCK) licenses manufacturers, importers and wholesalers, while the Social Security Institution (SGK) reimburses the vast majority of prescriptions through its pharmacy protocol and sets the reference prices that define margins along the chain. Hospitals belonging to the Ministry of Health buy through the Public Hospitals General Directorate and the state procurement office DMO, and private hospital groups such as Acıbadem, Medical Park and Memorial purchase directly from manufacturers and wholesalers. This directory covers the national and regional wholesalers, the pharmacist cooperatives, the public buyers and payer, and the logistics providers that constitute pharmaceutical distribution in Turkey, organised by the role each plays.

    Updated September 2026 · Türkiye İlaç ve Tıbbi Cihaz Kurumu (TİTCK) — licensed pharmaceutical wholesalers (ecza depoları) register as of September 2026 · 15 named accounts

    Request a proposal for TurkeyBrowse the 15 companies

    $9bn+

    Turkish pharmaceutical market by value, 2024 estimate

    ~28,000

    Pharmacist-owned community pharmacies

    ~90%

    Share of prescriptions reimbursed by SGK

    5

    National wholesalers handling most private-channel volume

    Named accounts

    Top pharmaceutical distributors in Turkey

    Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against Türkiye İlaç ve Tıbbi Cihaz Kurumu (TİTCK) — licensed pharmaceutical wholesalers (ecza depoları) register (as of 2026-09-03).
    #CompanyHQ
    01Selçuk Ecza DeposuIstanbul
    02Hedef Alliance (Alliance Healthcare Türkiye)Istanbul
    03Nevzat Ecza DeposuIstanbul
    04As Ecza DeposuIstanbul
    05Bahar Ecza DeposuAnkara
    06EDAK (Ege Eczacılar Kooperatifi)İzmir
    07BEK (Bursa Eczacılar Kooperatifi)Bursa
    08TEKB (Tüm Eczacı Kooperatifleri Birliği)Ankara
    09Sosyal Güvenlik Kurumu (SGK)Ankara
    10Devlet Malzeme Ofisi (DMO)Ankara
    11Public Hospitals General Directorate — ProcurementAnkara
    12Acıbadem Healthcare Group — Central PurchasingIstanbul
    13Ekol Logistics (Healthcare)Istanbul
    14DHL Supply Chain Türkiye (Life Sciences)Istanbul
    15Abdi İbrahimIstanbul

    Primary research

    These are the distributors and wholesalers we map in Turkey

    Choosing or auditing a distribution partner in Turkey? BioNixus runs distributor due-diligence interviews, channel-share estimates and pharmacy-level availability checks. Proposal ready within 48 hours of a brief.

    Planning research in Turkey?

    Primary research, market access & HEOR. A 30-minute scoping call, then a costed proposal within 48 hours.

    What happens on the call

    • We pin down the decision your research has to support.
    • We check feasibility: respondent types, countries and timeline.
    • You receive a costed proposal within 48 hours of the call.

    Top market research companies in Turkey (2026)

    How the market is structured

    How pharmaceutical distribution works in Turkey

    Manufacturers and importers licensed by TİTCK sell almost exclusively to wholesalers, because Turkish law prohibits pharmacy chains and pharmacies are too numerous and fragmented to serve directly. Selçuk Ecza Deposu and Hedef Alliance are the two national leaders, followed by Nevzat, As Ecza and Bahar, and together these five carry most of the private-channel volume through dozens of regional depots that deliver to pharmacies two or three times a day. Pharmacist cooperatives such as EDAK in the Aegean, BEK in Bursa and the members of the TEKB union hold a meaningful share in their regions and negotiate collectively with manufacturers. Pharmacies dispense under the SGK pharmacy protocol, which reimburses at reference prices and imposes fixed retail margins, so wholesalers compete on delivery speed, credit terms and IT integration with pharmacy software rather than on price. The public channel is separate: Ministry of Health hospitals buy through tenders run by the Public Hospitals General Directorate and via DMO framework contracts, and university and private hospitals tender or negotiate directly. Cold-chain biologics, oncology and specialty products are increasingly handled through dedicated wholesaler units or 3PLs such as Ekol Logistics, and the İTS track-and-trace system requires every pack to be serialised and scanned at each step from manufacturer to pharmacy.

    Local

    Turkish-owned national and regional wholesalers plus pharmacist cooperatives licensed by TİTCK to buy from manufacturers and deliver to pharmacies and hospitals multiple times a day.

    • Selçuk Ecza Deposu
    • Nevzat Ecza Deposu
    • As Ecza Deposu
    • Bahar Ecza Deposu
    • EDAK (Ege Eczacılar Kooperatifi)
    • BEK (Bursa Eczacılar Kooperatifi)
    • TEKB (Tüm Eczacı Kooperatifleri Birliği)
    • Abdi İbrahim

    Multinational

    Foreign-owned wholesale and logistics operators, led by Hedef Alliance and international 3PLs, that bring pre-wholesale, serialisation and cold-chain services to the Turkish market.

    • Hedef Alliance (Alliance Healthcare Türkiye)
    • DHL Supply Chain Türkiye (Life Sciences)

    Regional

    Cross-border groups using Turkey as a manufacturing and re-export base for the Caucasus, Central Asia and the Middle East, often pairing Turkish wholesalers with export logistics.

    Wholesalers, importers & 3PL

    The national payer, the state procurement bodies and the private hospital operators whose reimbursement rules, tenders and formularies decide what the wholesalers actually move.

    • Sosyal Güvenlik Kurumu (SGK)
    • Devlet Malzeme Ofisi (DMO)
    • Public Hospitals General Directorate — Procurement
    • Acıbadem Healthcare Group — Central Purchasing
    • Ekol Logistics (Healthcare)

    What is moving

    What is moving pharma distribution in Turkey

    Reference pricing and currency adjustments

    The euro-linked reference price used by SGK is updated periodically against the lira, and each adjustment changes wholesaler margins and stock valuations, making inventory timing a competitive lever.

    City hospitals and public tender scale

    The PPP city hospital programme has concentrated tertiary demand into very large tenders run through the Public Hospitals General Directorate and DMO, favouring wholesalers with hospital logistics and tender desks.

    Local production incentives

    Localisation policies tie reimbursement and tender advantages to domestic manufacturing, prompting multinationals to license or contract-manufacture with Turkish producers and altering which products wholesalers prioritise.

    Serialisation and specialty logistics

    The İTS track-and-trace system and growth in biologics and oncology are pushing wholesalers and 3PLs to invest in serialisation, cold rooms and direct-to-hospital specialty channels.

    BioNixus fieldwork

    How BioNixus studies pharmaceutical distributors in Turkey

    The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in Turkey:
    • Wholesaler service benchmarking: 60–100 pharmacist interviews across Istanbul, Ankara, İzmir, Bursa, Antalya and eastern provinces rating delivery frequency, credit days, IT integration and stock-out handling by depot.
    • Share-of-wholesaler estimates by region from pharmacy purchase-record audits of defined chronic, OTC and specialty baskets.
    • Public hospital and city hospital tender landscaping: bidders, award prices and wholesaler participation across recent cycles.
    • Specialty and cold-chain channel studies for oncology and biologics, covering wholesaler capabilities, 3PL use and direct-to-hospital models.

    Healthcare market research in Turkey

    Questions

    Frequently Asked Questions

    Can pharmaceutical companies sell directly to pharmacies in Turkey?

    In practice no. With around 28,000 independent pharmacies and no chains, manufacturers and importers rely on licensed ecza depoları and cooperatives for retail distribution, though they sell directly to hospitals through tenders.

    Which wholesalers dominate Turkish pharmaceutical distribution?

    Selçuk Ecza Deposu and Hedef Alliance lead nationally, with Nevzat, As Ecza and Bahar completing the group of five national wholesalers that handle most private-channel volume, alongside regional pharmacist cooperatives.

    How does SGK affect distribution?

    SGK reimburses roughly nine in ten prescriptions at reference prices and fixes retail margins through the pharmacy protocol. Inclusion on its reimbursement list is therefore the precondition for volume, and its price updates directly reshape wholesaler economics.

    What role do pharmacist cooperatives play?

    Cooperatives such as EDAK and BEK, coordinated through TEKB, act as regional wholesalers owned by their member pharmacists. They hold significant share in the Aegean, Marmara and southern regions and negotiate collectively with manufacturers.

    What does BioNixus research about pharmaceutical distributors in Turkey?

    Wholesaler service benchmarking from pharmacist interviews across Istanbul, Ankara, İzmir and Anatolian provinces; share-of-wholesaler estimates from pharmacy purchase records; public and private hospital tender mapping; and cold-chain and specialty-channel readiness studies for biologics launches.

    Does the order of this list reflect wholesaler size?

    No. Organisations are grouped by role and appear because they recur in BioNixus fieldwork in Turkey and on TİTCK licensing records; position within the table does not indicate revenue.

    Sources

    Data sources & methodology

    This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in Turkey. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.

    Primary register: Türkiye İlaç ve Tıbbi Cihaz Kurumu (TİTCK) — licensed pharmaceutical wholesalers (ecza depoları) register, consulted 2026-09-03. Company classification (Local / MNC / Regional / wholesalers, importers & 3pl) reflects ownership and role in Turkey, not size.

    • Borsa Istanbul filings and annual reports for Selçuk Ecza Deposu, 2024–2025
    • Association of Research-Based Pharmaceutical Companies (AİFD) and İEİS market reports, 2024
    • Sosyal Güvenlik Kurumu reimbursement statistics and Public Hospitals General Directorate tender notices, 2024–2026
    • BioNixus Turkey pharmacy, hospital and wholesaler fieldwork, 2023–2026

    BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.

    48-hour proposal

    Need distributor and channel data in Turkey?

    Coverage, credit terms, cold-chain capability and share of pharmacy purchases by wholesaler — from the pharmacies and hospitals themselves, not a directory.

    Planning research in Turkey?

    Primary research, market access & HEOR. A 30-minute scoping call, then a costed proposal within 48 hours.

    What happens on the call

    • We pin down the decision your research has to support.
    • We check feasibility: respondent types, countries and timeline.
    • You receive a costed proposal within 48 hours of the call.